About
Hitgen Inc. Class A — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 29 2026
ESG | HitGen Releases 2025 Sustainability Report
Apr 2 2026
Mission BioCapital Announces Opening of $4 Million 2026 Platinum Program Contest and 2025 Platinum Ticket Investments
Dec 15 2025
HitGen Submits Commitment Letter to Science Based Targets initiative (SBTi)
Nov 20 2025
HitGen Receives New Funding to Discover Novel Therapeutics for Underserved Diseases
Sep 15 2025
HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor
Translate